Market cap
₹70 Cr
Revenue (TTM)
₹59 Cr
P/E Ratio
13.8
P/B Ratio
1
Div. Yield
0 %
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
70 | 24,047 | 22,521 | 19,602 | 16,799 |
Revenue (₹ Cr) |
59 | 8,575 | 1,224 | 9,013 | 2,258 |
Net Profit (₹ Cr) |
5.64 | 783.41 | 235.19 | 531.00 | 387.86 |
Net Margin (%) |
9.42 | 9.08 | 18.79 | 5.88 | 16.65 |
RoE (%) |
7.98 | 13.96 | 10.03 | 8.95 | 15.03 |
Price to Earnings |
13.81 | 30.70 | 95.76 | 36.91 | 43.31 |
Price-To-Book |
1.04 | 3.89 | 8.95 | 3.22 | 6.02 |
Income Statement (₹ Cr)
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Operating Revenue
|
58.75 | 8,574.79 | 1,223.90 | 9,013.00 | 2,258.20 |
|
Total Income
|
59.86 | 8,624.11 | 1,251.61 | 9,023.00 | 2,329.38 |
|
Total Expenditure
|
50.88 | 7,243.44 | 839.85 | 7,681.00 | 1,761.06 |
|
EBITDA
|
7.87 | 1,331.35 | 384.05 | 1,332.00 | 497.14 |
|
Depreciation
|
1.02 | 237.05 | 73.63 | 484.00 | 47.37 |
|
EBIT
|
6.85 | 1,094.30 | 310.42 | 848.00 | 449.77 |
|
Interest
|
0.41 | 60.80 | 18.87 | 364.00 | 8.60 |
|
Other Income
|
1.12 | 49.32 | 27.71 | 10.00 | 71.18 |
|
Exceptional Items
|
0.00 | -12.84 | -6.34 | 8.00 | 0.00 |
|
Profit before Tax
|
7.56 | 1,069.98 | 312.91 | 502.00 | 512.35 |
|
Provision for Tax
|
1.92 | 286.57 | 77.72 | -29.00 | 124.49 |
|
Profit after Tax
|
5.64 | 783.41 | 235.19 | 531.00 | 387.86 |
Liabilities (₹ Cr)
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
68.78 | 5,836.83 | 2,455.89 | 5,955.00 | 2,656.16 |
|
Minority Interest
|
-0.63 | -0.15 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
4.17 | 1,532.66 | 88.20 | 2,306.00 | 62.64 |
|
Current Liabilities
|
15.38 | 1,278.74 | 657.34 | 5,038.00 | 292.39 |
|
Total Liabilities
|
-- | 7,706.02 | -- | 11,113.52 | 2,681.99 |
Assets (₹ Cr)
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
41.96 | 5,145.91 | 1,754.09 | 8,995.00 | 1,684.25 |
|
Current Assets
|
47.41 | 3,069.38 | 1,171.47 | 4,187.00 | 1,295.48 |
|
Total Assets
|
-- | 7,706.02 | -- | 11,113.52 | 2,681.99 |
|
Total Debt*
|
-- | 1,170.53 | -- | 3,789.55 | 15.21 |
|
Net Current Assets
|
32.03 | 1,790.64 | 514.14 | -851.00 | 1,003.09 |
|
Contingent Liabilities
|
-- | 0.53 | -- | 320.61 | 108.28 |
Cashflow (₹ Cr)
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | 624.70 | -- | 1,237.62 | 329.72 |
|
Cash Flow from Investing Activities
|
-- | -1,491.33 | -- | -1,393.35 | -274.50 |
|
Cash from Financing Activities
|
-- | 806.16 | -- | -73.17 | -52.05 |
|
Net Cash Inflow / Outflow
|
-- | -60.47 | -- | -228.90 | 3.17 |
Ratios
Profitability Ratios
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-- | 17.00 | -- | 6.39 | 20.41 |
|
ROE (%)
|
7.98 | 13.96 | 10.03 | 8.95 | 15.03 |
|
ROA (%)
|
7.26 | 9.55 | 8.05 | 4.35 | 13.63 |
|
EBIT Margin (%)
|
11.66 | 12.76 | 25.36 | 9.41 | 19.92 |
|
Net Margin (%)
|
9.42 | 9.08 | 18.79 | 5.88 | 16.65 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
56.13 | 7.12 | 33.72 | 27.03 | 6.02 |
|
EBIT Growth (%)
|
124.34 | 41.57 | 34.90 | 85.15 | 15.14 |
|
Net Profit Growth (%)
|
92.03 | 29.05 | 34.01 | 124.05 | 19.02 |
|
EPS Growth (%)
|
90.23 | 30.59 | 30.29 | 123.11 | 19.02 |
|
Book Value Growth (%)
|
-- | 12.34 | -- | 5.85 | 15.99 |
Valuation Ratios
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Price / Earnings
|
13.25 | 30.34 | 93.81 | 37.53 | 43.31 |
|
Price / Book Value
|
1.04 | 3.89 | 8.95 | 3.21 | 6.02 |
|
Dividend Yield (%)
|
0.00 | 0.43 | 0.00 | 0.19 | 0.17 |
|
EV/EBITDA
|
7.79 | 18.86 | 59.78 | 17.95 | 32.51 |
|
Market Cap (₹ Cr)
|
-- | 27,044.64 | -- | 14,156.47 | 9,144.50 |
Solvency Ratios
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.04 | 0.19 | 0.00 | 0.37 | 0.00 |
|
Short term debt to equity ratio
|
0.02 | 0.03 | -- | 0.30 | -- |
|
Current Ratio
|
3.08 | 2.40 | 1.78 | 0.83 | 4.43 |
|
Quick Ratio
|
2.82 | 1.73 | 0.96 | 0.49 | 3.10 |
|
Interest Coverage
|
19.34 | 18.60 | 17.58 | 2.38 | 60.58 |
Operating Efficiency Ratios
| Eiko Lifesciences | Deepak Nitrite | Aether | Aarti | Garware Hi-Tech | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
34.42 | 17.56 | 31.87 | 15.57 | 2.35 |
|
Asset Turnover
|
0.76 | 1.05 | 0.42 | 0.74 | 0.79 |
|
Receivable days
|
-- | 56.28 | -- | 37.06 | 6.92 |
|
Inventory Days
|
-- | 36.90 | -- | 59.06 | 51.75 |
|
Payable days
|
-- | 33.64 | -- | 84.85 | 57.67 |
|
Cash Conversion Cycle
|
-- | 59.53 | -- | 11.27 | 1.00 |